Remedies Centred Around Diagnostics and Metabolic Solutions
Your One-Stop-Shop for Healthier Living and Disease Prevention
Dynamic Diagnostic And Nutraceutical Innovation
Diagnostics
The world’s first blood test for the early detection of all cancers.
Sugars
Natural sugars that improve everyday well-being.
Dynamic Diagnostic And Nutraceutical Innovation
With its translational approach and TKTL1 focus, RMDM is driving targeted medical solutions while creating a biological model for health- bridging molecular research with real-world clinical strategies.
Diagnostics
The world’s first blood test for the early detection of all cancers.
Sugars
Natural sugars that improve everyday well-being.
New Release: 2024 Edition of PanTum Detect Whitepaper
This 2024 edition highlights groundbreaking findings in liquid biopsy and multi-cancer detection, demonstrating the immense potential of the PanTum Detect test to transform early cancer screening programs.
Dive into the comprehensive analysis and see how PanTum Detect can provide a first point of information that will help save more lives and meet cancer targets in the UK and worldwide.
Latest News
Jordan: When Data is Strong but Early Detection Still Lags
Jordan has strong medical expertise and one of the region’s most robust cancer registries, but a key challenge remains turning insight into early detection. Cancer is now a leading cause of death, and while treatment capacity is advanced, screening and…
Early Cancer Detection in the Middle East: Why Technology Alone is Not Enough
Across the Middle East, rapid investment in healthcare is transforming cancer care, with advanced technologies and screening programmes expanding across countries like Kuwait, Jordan, Saudi Arabia, and Iraq. Yet a key challenge remains: many patients are still diagnosed at later…
The Limits of the Galleri Approach and the Strengths of Biologically Grounded Liquid Biopsy
The recent failure of the large-scale study evaluating the Galleri blood test represents an important inflection point after years of intense enthusiasm surrounding the concept of a single blood test capable of detecting more than fifty cancers. The outcome underscores…
Cancer Deaths in Scotland Are Falling and Early Action Is Making the Difference
Cancer death rates in Scotland have fallen by around 11 percent over the past decade, showing the impact of earlier diagnosis, better treatment, and sustained investment in cancer services. But with total deaths still rising due to an ageing population,…
Latest Breakthroughs in Early Cancer Detection – 2026 Update: Multi-Cancer Blood Tests and AI Diagnostics
By Dr. Letizia Gulino, PhD Head of Science & Technology, RMDM Group Dr. Letizia Gulino is the Head of Science and Technology at RMDM Group, bringing over 20 years of extensive experience in molecular medicine research and private sector innovation.…
Dr. Johannes Coy on His Metabolic Approach to Cancer
In Top Magazin Frankfurt, Dr. Johannes Coy describes how his discovery of the TKTL1 “master switch” led to breakthroughs in therapy, early tumour detection, and blood-sugar-friendly nutrition. At RMDM, this science forms the foundation of our One Stop Shop approach…
Distressing BBC Report on Northern Ireland Breast Cancer Delays
The BBC’s newly published investigation exposes a system under severe strain: red-flag breast cancer patients in Northern Ireland waiting 8–10 weeks for assessment against a 14-day target, stage 2–4 cancers developing during delays, and a regional service so overwhelmed that…
TKTL1: The Metabolic Sensor Linking Cellular Metabolism and Proliferation
Recent research has revealed a remarkable link between how cells manage energy and nutrients and the timing of their division. At the center of this process is TKTL1, a key metabolic enzyme that functions as a sensor, monitoring the cell’s…
Early Cancer Detection: Methods, Benefits, and Screening Options
By Dr. Letizia Gulino, PhD Head of Science & Technology, RMDM Group Dr. Letizia Gulino is the Head of Science and Technology at RMDM Group, bringing over 20 years of extensive experience in molecular medicine research and private sector…
Independent Validation of Apo10 and TKTL1 Biomarkers Strengthens PanTum Detect’s Scientific Foundation
A recently published study in BMC Medicine provides strong, independent evidence supporting the clinical utility of the EDIM-based biomarkers Apo10 and TKTL1 for the early detection of cervical cancer. These are the same two biomarkers at the heart of RMDM’s…